Biogen Ma Inc.

Brain Computer Interface LLC

Ajay Verma

John William Hoppin

Ara N Knaian

Seth O Newburg

Karl F Schmidt

Courtney D Hilliard

Marisa J Bober

Victoria Cabot

Jack Hoppin

Ira Spool

Jacob Yost Hesterman

Adam Jay Simon

Elliot Greenblatt

Rachel M Chaney

Guy M Danner

Embodiments related to methods and wearable medical detecting systems for detecting disease states and/or treatment states of a subject are described. In one embodiment, a wearable structure may include one or more radiation detectors use to detect a time varying radiation signal emitted from a labeled compound within a body portion of interest. The radiation signal may be analyzed to determine one or more signal characteristics that may be compared to one or more predetermined standard characteristics associated with known disease and/or treatment states to determine a current disease and/or treatment state of a subject.

Medical diagnostic and treatment systems and their methods of use

Wearable apparatus and method of using same for tracking a labeled probe in a subject are disclosed.

Assessment of labeled probes in a subject

Various embodiments of medical detector systems as well as their methods of operation are disclosed. In one embodiment, one or more detectors are coupled to wearable structures for detecting at least a first tracer within a body portion. In another embodiment, one or more detectors are coupled to a wearable structure, where the detector corresponds to a CMOS chip that directly detects a first radioactive tracer.

Wearable medical detector

The invention provides compositions and methods for evaluating neuromuscular function in a subject, e.g., a subject at risk for or suffering from a neuromuscular disorder.

Compositions and methods for assessing neuromuscular function

Methods and apparatuses for dispersing a compound within the patient are described. In one embodiment, an effective amount of a compound may be present in the cerebrospinal fluid of a patient and a force may be applied to the torso of the patient sufficient to enhance the convection of the cerebrospinal fluid. In another embodiment, a bolus including a compound may be injected into the cerebrospinal fluid of a patient. The volume of the bolus may be between about 5% and 30% of the total volume of the cerebrospinal fluid of the patient.

Apparatus for compound dispersion

Display screen with a graphical user interface

Growing community of inventors

Needham, MA, United States of America

Ajay Verma